Price Movement and Market Context
On the day the new low was hit, Trident Texofab opened sharply down by 4.98%, trading at Rs.42.73 throughout the session without recovering. This performance notably underperformed its sector by 4.73%, signalling relative weakness within the Garments & Apparels industry. The stock is currently trading below all key moving averages – 5-day, 20-day, 50-day, 100-day, and 200-day – underscoring a bearish technical setup.
The broader market environment also reflected caution, with the Sensex reversing sharply after a positive start. Despite opening 323.83 points higher, the benchmark index fell by 396.25 points to close at 75,430.43, marginally down by 0.1%. The Sensex itself is trading below its 50-day moving average, which in turn is below the 200-day moving average, indicating a bearish trend in the wider market.
Long-Term Performance and Valuation
Over the past year, Trident Texofab has delivered a return of -75.44%, significantly underperforming the Sensex’s modest gain of 1.65% during the same period. The stock’s 52-week high was Rs.379, highlighting the extent of the decline from its peak. This prolonged underperformance is also evident in the company’s relative standing against the BSE500 index, where it has lagged over one, three years, and the last three months.
Despite the weak price performance, the company’s valuation metrics present a mixed picture. Trident Texofab’s Return on Capital Employed (ROCE) stands at a modest 6.88%, reflecting limited capital efficiency. The Debt to EBITDA ratio is elevated at 6.83 times, indicating a relatively high leverage burden that may constrain financial flexibility. However, the Enterprise Value to Capital Employed ratio is 1.1, suggesting the stock is trading at a discount compared to its peers’ historical valuations.
Momentum just kicked in! This Small Cap from the Auto - Trucks sector entered our list with explosive short-term signals. Catch the wave while it's still building!
- - Fresh momentum detected
- - Explosive short-term signals
- - Early wave positioning
Financial Results and Profitability Trends
The company reported flat quarterly results for the period ending December 2025, with net sales at Rs.25.74 crores, marking the lowest quarterly sales figure in recent times. Despite the subdued top line, profits have risen by 122.5% over the past year, a notable improvement that contrasts with the stock’s price trajectory. This disparity is reflected in the company’s Price/Earnings to Growth (PEG) ratio of 0.4, indicating that earnings growth is not currently mirrored in the share price.
Nonetheless, the company’s ability to service debt remains a concern given the high leverage ratio. The combination of modest capital returns and elevated debt levels contributes to the stock’s current grading as a Strong Sell, an upgrade from its previous Sell rating as of 3 Feb 2026, according to MarketsMOJO’s assessment. The Mojo Score stands at 23.0, reinforcing the cautious stance on the stock.
Technical Indicators and Market Sentiment
Technical analysis further highlights the bearish outlook. The Moving Average Convergence Divergence (MACD) indicator is bearish on a weekly basis and mildly bearish monthly. Bollinger Bands also signal bearish trends across weekly and monthly charts. The KST (Know Sure Thing) indicator aligns with this view, showing bearish momentum weekly and mildly bearish monthly. The Dow Theory readings are mildly bearish on both weekly and monthly timeframes. Relative Strength Index (RSI) does not currently signal any oversold or overbought conditions, suggesting the downtrend may continue without immediate reversal signals.
Majority shareholding remains with non-institutional investors, which may influence liquidity and trading dynamics in the stock.
Trident Texofab Ltd or something better? Our SwitchER feature analyzes this micro-cap Garments & Apparels stock and recommends superior alternatives based on fundamentals, momentum, and value!
- - SwitchER analysis complete
- - Superior alternatives found
- - Multi-parameter evaluation
Summary of Key Metrics
To summarise, Trident Texofab Ltd’s current market position is characterised by:
- A 52-week low price of Rs.42.73 reached on 17 Mar 2026
- 21 consecutive days of price decline, with a cumulative loss of 65.83%
- Underperformance relative to the Sensex and sector benchmarks
- Weak long-term capital efficiency with ROCE at 6.88%
- High leverage with Debt to EBITDA ratio of 6.83 times
- Flat quarterly sales at Rs.25.74 crores in December 2025 quarter
- Profit growth of 122.5% over the past year despite price decline
- Bearish technical indicators across multiple timeframes
- Strong Sell Mojo Grade with a score of 23.0 as of 3 Feb 2026
These factors collectively illustrate the challenges faced by the stock in maintaining upward momentum and highlight the prevailing cautious sentiment among market participants.
Limited Period Only. Get Started for only Rs. 16,999 - Get MojoOne for 2 Years + 1 Year Absolutely FREE! (72% Off) Get 72% Off →
